NCT01126112

Study of First-line Single-agent Panitumumab in Frail Elderly Patients With Advanced Wild Type K-RAS Colorectal Cancer

Phase II Study of First-line Single-agent Panitumumab in Frail Elderly Patients With Advanced Wild Type K-RAS Colorectal Cancer

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 33 (actual)
• Sponsor: Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) · Academic / Other
• Sex: All
• Age: 70 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the study is to evaluate the efficacy and safety of first-line single-agent panitumumab in frail elderly patients with advanced Wild Type K-RAS colorectal cancer

Detailed description

The purpose of the study is to evaluate the efficacy and safety of first-line single-agent panitumumab in frail elderly patients with advanced Wild Type K-RAS colorectal cancer

Conditions

• Colorectal Cancer

Interventions

Type	Name	Description
BIOLOGICAL	Panitumumab	Panitumumab: 6 mg/Kg Q2W

Timeline

• Start date: 2010-05-01
• Primary completion: 2014-07-01
• Completion: 2014-07-01
• First posted: 2010-05-19
• Last updated: 2015-03-24

Locations

1 site across 1 country: Spain